Please note this application is under active development. If you spot any errors or something isn't working, please contact us at evidence.service@wales.nhs.uk.

Reducing sexually transmitted infections (STIs) [F] Evidence reviews for increasing uptake of hepatitis A, hepatitis B and human papillomavirus (HPV) vaccinations in gay, bisexual and other men who have sex with men

National Institute for Health and Care Excellence (2021)

NICE - N/A

Evidence Categories

  • Care setting: Other settings
  • Population group: Men who have sex with men
  • Intervention: Other Intervention
  • Intervention: Reminder/recall (patient)
  • Intervention: Health literacy
  • Intervention: Multicomponent Interventions
  • Intervention: Improving access
  • Outcome: Uptake of vaccinations
  • Outcome: Change in vaccination rates
  • Outcome: Other

Type of Evidence

NICE Underpinning Review

Overview

The authors state:

The committee discussed the lack of evidence for interventions to facilitate vaccine completion for gay, bisexual and other men who have sex with men and emphasised the importance of people having all doses of the vaccine to be fully protected. They agreed that both the quantitative and qualitative evidence focused largely on vaccine initiation so there was an evidence gap relating to vaccine completion. They considered that understanding the barriers to vaccine course completion would help to support eligible gay, bisexual and other men who have sex with men to have all vaccine doses to obtain full protection.

The effectiveness evidence showed that text-messaging based interventions designed to increase vaccine uptake were effective at increasing HPV vaccine initiation. Similarly, an intervention focusing on implementation intention formation (prompting participants to 8 consider ways to implement their intentions to get vaccinated by thinking about when, where 9 and how they would obtain hepatitis B vaccine) was effective at increasing hepatitis B vaccine initiation in MSM.

The text-messaging based interventions were not effective in supporting HPV vaccine completion and there were no studies that examined hepatitis B  vaccine completion. The qualitative evidence generated themes that showed a lack of information about HPV, HPV-related disease, and the HPV vaccine was a barrier to vaccination in MSM. This supports findings from the effectiveness review because the interventions that were effective at increasing vaccination initiation included information-based components that educated people about HPV and HPV-related disease.

Recommendations

The authors state:

This evidence review supports recommendations 1.4.1 to 1.4.4 and the research 21 recommendation on barriers to vaccination course completion.